胆汁淤积
药品
肝损伤
毒性
体内
体外
药理学
肝细胞
肝毒性
胆汁酸
医学
化学
生物
生物化学
内科学
生物技术
作者
Eva Gijbels,Vânia Vilas‐Boas,Neel Deferm,Lindsey Devisscher,Hartmut Jaeschke,Pieter Annaert,Mathieu Vinken
标识
DOI:10.1007/s00204-019-02437-2
摘要
Cholestasis underlies one of the major manifestations of drug-induced liver injury. Drug-induced cholestatic liver toxicity is a complex process, as it can be triggered by a variety of factors that induce 2 types of biological responses, namely a deteriorative response, caused by bile acid accumulation, and an adaptive response, aimed at removing the accumulated bile acids. Several key events in both types of responses have been characterized in the past few years. In parallel, many efforts have focused on the development and further optimization of experimental cell culture models to predict the occurrence of drug-induced cholestatic liver toxicity in vivo. In this paper, a state-of-the-art overview of mechanisms and in vitro models of drug-induced cholestatic liver injury is provided.
科研通智能强力驱动
Strongly Powered by AbleSci AI